4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%

MT Newswires Live
Jan 30

4DMedical (ASX:4DX) expanded its partnership with the University of Chicago Medicine to include commercial deployment of CT:VQ cardiothoracic imaging product, according to a Friday Australian bourse filing.

The University of Chicago Medicine will become the fifth US academic medical center to adopt the CT:VQ product, per the filing.

The expanded arrangement includes a renewed imaging analysis platform agreement and a commercial contract, including an initial package of prepaid CT:VQ scans to boost clinical deployment.

4DMedical's shares jumped past 7% in recent Friday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10